Sakyi, P.O.; Kwofie, S.K.; Tuekpe, J.K.; Gwira, T.M.; Broni, E.; Miller, W.A., III; Wilson, M.D.; Amewu, R.K.
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals 2023, 16, 330.
https://doi.org/10.3390/ph16030330
AMA Style
Sakyi PO, Kwofie SK, Tuekpe JK, Gwira TM, Broni E, Miller WA III, Wilson MD, Amewu RK.
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals. 2023; 16(3):330.
https://doi.org/10.3390/ph16030330
Chicago/Turabian Style
Sakyi, Patrick O., Samuel K. Kwofie, Julius K. Tuekpe, Theresa M. Gwira, Emmanuel Broni, Whelton A. Miller, III, Michael D. Wilson, and Richard K. Amewu.
2023. "Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling" Pharmaceuticals 16, no. 3: 330.
https://doi.org/10.3390/ph16030330
APA Style
Sakyi, P. O., Kwofie, S. K., Tuekpe, J. K., Gwira, T. M., Broni, E., Miller, W. A., III, Wilson, M. D., & Amewu, R. K.
(2023). Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling. Pharmaceuticals, 16(3), 330.
https://doi.org/10.3390/ph16030330